Preoperative Oral Nutritional Supplement (preOP Booster) in Visceral Surgery
NCT ID: NCT00503334
Last Updated: 2008-12-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2007-07-31
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
preOP booster
preOP booster (oral nutritional supplement, food for special medical purposes)
3x1 dosage pre-operatively
preOP booster placebo
preOP booster (oral nutritional supplement, food for special medical purposes)
3x1 dosage pre-operatively
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
preOP booster (oral nutritional supplement, food for special medical purposes)
3x1 dosage pre-operatively
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Severe malnutrition (SGA score C)
* Conditions affecting gastric emptying
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fresenius Kabi
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fresenius Kabi Deutschland GmbH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marco Braga, Prof MD
Role: PRINCIPAL_INVESTIGATOR
Università Salute-Vita San Raffaele, Milan, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Università Salute-Vita San Raffaele,
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-POB-03-IT
Identifier Type: -
Identifier Source: org_study_id